In Vitro Activities of Sitafloxacin (DU-6859a) and Six Other Fluoroquinolones against 8,796 Clinical Bacterial Isolates | Zendy

D. Milatović | Zendy; FranzJosef Schmitz | Zendy; Sylvain Brisse | Zendy; J. Verhoef | Zendy; Ad C. Fluit | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In Vitro Activities of Sitafloxacin (DU-6859a) and Six Other Fluoroquinolones against 8,796 Clinical Bacterial Isolates

Author(s) -

D. Milatović,

FranzJosef Schmitz,

Sylvain Brisse,

J. Verhoef,

Ad C. Fluit

Publication year - 2000

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.44.4.1102-1107.2000

Subject(s) - trovafloxacin , gatifloxacin , moxifloxacin , microbiology and biotechnology , ciprofloxacin , levofloxacin , peptostreptococcus , ofloxacin , antibacterial agent , gram positive cocci , anaerobic bacteria , biology , bacteria , staphylococcus aureus , antibiotics , genetics

The in vitro activities of sitafloxacin, ciprofloxacin, trovafloxacin, levofloxacin, clinafloxacin, gatifloxacin, and moxifloxacin against 5,046 gram-negative bacteria, 3,344 gram-positive cocci, and 406 anaerobes were determined. Sitafloxacin was the most active agent against gram-positive cocci and anaerobes. AgainstEnterobacteriaceae and nonfermenters, its activity was either equivalent to or better than that of clinafloxacin.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research